Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
This unprecedented precision stems from the peptide's targeting of a unique vulnerability in senescent cell biology, where FOXO4 prevents p53 from executing its normal pro-apoptotic function
Because the compound is sold on the gray market without routine independent oversight, purity and composition can vary between suppliers
Das US-amerikanische pharmazeutische Unternehmen Amylin entwickelte gentechnisch Exendin-4 und brachte es unter dem Namen Exenatid 2005 als Arzneistoff zur subkutanen Injektion fr Typ-II-Diabetiker in den Handel
195 Notably, non-histone Kla regulates Treg cell function
)
US$ 21.77
US$ 27.15
US$ 21.75
US$ 21.84
US$ 24.38
US$ 27.60
US$ 27.02
